XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities        
Net income before noncontrolling interests $ 52,480 $ 113,366 $ 182,090 $ 336,865
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization     5,618 5,081
Deferred income taxes 7,307 8,466 21,697 28,411
Noncash lease expense     1,271 (1,272)
Net investment (gain) loss on nonconsolidated investment securities     23,777 (2,230)
Net (gain) loss on the tax receivable agreements (431) (358) (913) (358)
(Gain) loss on disposal of property and equipment     (38) (1)
Amortization of debt issuance costs     329 304
Share-based compensation     31,613 30,099
Purchase of investments by consolidated investment products     (319,093) (190,614)
Proceeds from sale of investments by consolidated investment products     151,198 127,863
Change in assets and liabilities resulting in an increase (decrease) in cash:        
Accounts receivable     12,416 (22,260)
Prepaid expenses and other assets     2,527 (4,214)
Accounts payable and accrued expenses     94,611 113,355
Net change in operating assets and liabilities of consolidated investment products     84,838 1,205
Net cash provided by operating activities     306,622 404,168
Cash flows from investing activities        
Acquisition of property and equipment     (5,284) (1,791)
Leasehold improvements     (11,007) (3,338)
Proceeds from sale of investment securities     5,164 12,813
Purchase of investment securities     (49,337) (33,820)
Net cash used in investing activities     (60,464) (26,136)
Cash flows from financing activities        
Partnership distributions     (43,721) (67,889)
Dividends paid     (210,306) (203,471)
Payment of debt issuance costs     (543) 0
Proceeds from issuance of notes payable     90,000 0
Principal payments on notes payable     (90,000) 0
Payment under the tax receivable agreements     (33,109) (31,250)
Net proceeds from issuance of common stock     0 46,928
Payment of costs directly associated with the issuance of Class A common stock     0 (244)
Purchase of equity and subsidiary equity     0 (46,928)
Taxes paid related to employee net share settlement     (7,754) (9,159)
Capital contributions to consolidated investment products, net     36,126 59,818
Net cash used in financing activities     (259,307) (252,195)
Net increase (decrease) in cash, cash equivalents, and restricted cash     (13,149) 125,837
Net cash impact of deconsolidation of CIPs 0 (34,823) 0 (34,823)
Cash, cash equivalents and restricted cash        
Beginning of period     200,771 199,450
End of period 187,622 290,464 187,622 290,464
Cash, cash equivalents and restricted cash as of the end of the period        
Restricted cash 629 629 629 629
Cash, cash equivalents and restricted cash 187,622 290,464 187,622 290,464
Noncash activity:        
Establishment of deferred tax assets     8,327 28,548
Establishment of amounts payable under tax receivable agreements     5,929 23,206
Increase in investment securities due to deconsolidation of CIPs     9,970 20,900
Operating lease assets obtained in exchange for operating lease liabilities     32,070 2,434
Consolidated Entity Excluding Variable Interest Entities (VIE)        
Adjustments to reconcile net income to net cash provided by operating activities:        
Net investment (gain) loss of consolidated investment products 5,563 2,109 23,729 (2,022)
Consolidated Entity, Excluding VIE        
Adjustments to reconcile net income to net cash provided by operating activities:        
Net investment (gain) loss of consolidated investment products 5,563 2,109 23,729 (2,022)
Cash, cash equivalents and restricted cash as of the end of the period        
Cash and cash equivalents 168,123 273,253 168,123 273,253
Variable Interest Entity, Primary Beneficiary        
Adjustments to reconcile net income to net cash provided by operating activities:        
Net investment (gain) loss of consolidated investment products 3,936 (2,824) 14,605 (18,068)
Cash, cash equivalents and restricted cash as of the end of the period        
Cash and cash equivalents $ 18,870 $ 16,582 $ 18,870 $ 16,582